企業概要
GoHealth, Inc. operates as a prominent health insurance marketplace and Medicare-focused digital health company within the United States, offering a comprehensive suite of Medicare plans that include Medicare Advantage, Medicare supplement, prescription drug plans, and special needs plans. The company functions within the Financial Services sector, specifically the Insurance Brokers industry, which involves facilitating the purchase of insurance policies for individual or group clients. In terms of corporate scale, GoHealth, Inc. holds a market capitalization of $30.29M and reports an annual revenue of $361.84M over the trailing twelve months, while employing approximately 850 individuals. These valuation and revenue figures indicate that the company operates with a relatively modest market capitalization relative to its reported revenue, suggesting a specific position in the market that may reflect recent operational challenges or a distinct capital structure compared to larger peers in the insurance brokerage space.
財務健全性
The financial performance of GoHealth, Inc. is characterized by a revenue of $361.84M, which contrasts sharply with a net income of -$261,050,000 and an EBITDA of -$79,834,000, revealing a significant gap where operating costs and expenses substantially exceed gross profits. The company reports a free cash flow of -$113,457,504, indicating a current lack of financial flexibility to fund operations or growth initiatives without external capital injection. Margin analysis shows a gross margin of 73.4%, suggesting efficient cost control in generating revenue, yet this is offset by a negative operating margin of -252.9% and a profit margin of -71.1%, highlighting severe operational inefficiencies or high general and administrative expenses. On the balance sheet, the company holds cash of $32.90M against a total debt load of $672.59M, while the debt-to-equity ratio is listed as N/A, pointing to a highly leveraged position where debt significantly outweighs available liquid assets. Liquidity is supported by a current ratio of 2.02, which suggests the company maintains sufficient current assets to cover its short-term liabilities, though this does not mitigate the long-term solvency risks posed by the high debt burden. Return on Equity stands at -219.7% and Return on Assets is -7.7%, metrics that indicate management is currently generating substantial losses on both shareholder equity and total asset base, reflecting a period of negative capital efficiency.
バリュエーション評価
Valuation metrics for GoHealth, Inc. present a complex picture, with a trailing P/E ratio listed as N/A due to negative earnings, while the forward P/E is reported at -0.27, implying that future earnings are also expected to remain negative in the near term. The price-to-book ratio is 0.45, indicating that the market values the company at less than half of its book value, which typically suggests a deep discount relative to the company's tangible assets or potential value destruction. Alternative valuation measures such as the price-to-sales ratio of 0.08 and an EV/EBITDA of -7.68 further underscore the distressed nature of the valuation, as these negative or near-zero multiples reflect the absence of traditional profitability drivers. The stock has experienced significant volatility, trading between a 52-week high of $11.36 and a 52-week low of $1.00, with the current trading price situated well below the 52-week high and reflecting the uncertainty surrounding the company's recovery. The beta value of 1.60 indicates that the stock's price volatility is significantly higher than the broader market, moving 60% more than the market index in response to general market fluctuations.
Growth & Income
Growth metrics reveal a revenue decline of -96.8% year-over-year, while earnings growth is listed as N/A due to the company's loss-making status, indicating that the business is currently contracting rather than expanding. Since the company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, it is not distributing cash to shareholders, which means any generated cash flow is retained or used to service debt rather than being paid out. The absence of a dividend yield and the negative earnings growth rate suggest that the company is in a phase of restructuring or significant operational adjustment rather than organic expansion. Overall, the growth and income profile is defined by sharp revenue contraction and a complete lack of income generation or dividend distribution, presenting a scenario where capital preservation is the primary concern rather than wealth accretion or income generation.